glp-1 news october 9 2025 trends 2025: real-world data, patient outcomes & future therapies In the phase 3 ACHIEVE-1

Vitamin B12 supports neurological function and addresses potential B12 depletion from GLP-1 therapy

Consequently, TXN inhibitors remain both promising and complex as potential candidates in the fight against cancer

Microneedle patch delivery of methotrexate-loaded albumin nanoparticles to immune cells achieves a potent antipsoriatic effect

Effect of New Zealand blueberry consumption on recovery from eccentric exercise-induced muscle damage

Integrating ChIP-seq, HiC, and PRO-seq datasets, we revealed broad functional binding of NRF2 at enhancer elements, including NRF2-dependent enhancer-derived RNA (eRNA) synthesis and extensive linkages between NRF2 target promoters and enhancers

FEBS Letters 414, 567570